June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Investigating the role of mutational load and cis modifiers of disease severity in RHO P23H autosomal dominant Retinitis Pigmentosa
Author Affiliations & Notes
  • Riccardo Sangermano
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Egle Galdikaite-Braziene
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Erin Zampaglione
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Eric A Pierce
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Ayellet V. Segrè
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Jason Comander
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Kinga Maria Bujakowska
    Massachusetts Eye and Ear Department of Ophthalmology, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Riccardo Sangermano None; Egle Galdikaite-Braziene None; Erin Zampaglione None; Eric Pierce None; Ayellet Segrè None; Jason Comander None; Kinga Bujakowska None
  • Footnotes
    Support  NEI grant R01EY026904
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1594 – A0383. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Riccardo Sangermano, Egle Galdikaite-Braziene, Erin Zampaglione, Eric A Pierce, Ayellet V. Segrè, Jason Comander, Kinga Maria Bujakowska; Investigating the role of mutational load and cis modifiers of disease severity in RHO P23H autosomal dominant Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1594 – A0383.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The RHO-P23H mutation is a well-known cause of autosomal dominant Retinitis Pigmentosa. Although affected patients share the same primary sequence defect, their phenotype displays a spectrum of disease severity. We hypothesized that the phenotypic variability could be due to an increased mutational load in the known inherited retinal disease (IRD) genes or to a differentially expressed wild-type RHO allele, that alters the ratio of the wild-type and mutant rhodopsin protein. Therefore, we tested for correlation of: 1) sequence variability in known IRD genes; and 2) wild-type RHO allele haplotypes with RHO-P23H phenotype severity.

Methods : We investigated a cohort of 130 RHO-P23H patients. Variable retinal severity was documented by retrospective analysis of ophthalmological data. We selected electroretinographic (ERG) measurements, in particular the 30Hz flicker ERG amplitude as the most comprehensive single parameter demonstrating phenotypic variability, adjusted for age. Targeted sequencing of all known IRD genes and genotyping of the RHO locus were performed using an in-house sequencing panel and a genotyping array (Illumina GSA), respectively. Deleteriousness of rare IRD variants was assessed using CADD, where for each patient we summed CADD scores for rare (MAF=<0.05) high-impact (loss-of-function) and missense variants. Genotyped variants surrounding the RHO locus (850kb) were phased using Eagle-v2 and samples of European ancestry from the Haplotype Reference Consortium panel.

Results : No significant correlation (r2<0.01) was observed between retinal disease severity in RHO-P23H patients and the mutational load of rare loss-of-function or missense variants in other known IRD genes. Analysis of the RHO locus confirmed that the RHO-P23H allele is a founder allele in the US population, with only one family showing a different haplotype for the RHO-P23H allele. No particular wild-type allele segregated with mild or severe cases in any of the families.

Conclusions : Our results do not support two of our original hypotheses: 1) that mutational load in IRD genes can lead to the modulation of RHO-P23H disease severity, and 2) that the wild-type RHO allele can have an effect on disease severity. Differences in disease severity in the RHO-P23H patients may be the result of genetic modifiers elsewhere in the genome.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×